OverviewChartNewsTraderScreen

Goldman Sachs Knock-Out CHKP/  DE000GJ08K86  /

EUWAX
2024-09-02  9:57:42 AM Chg.-0.01 Bid10:00:26 PM Ask10:00:26 PM Underlying Strike price Expiration date Option type
2.30EUR -0.43% -
Bid Size: -		 -
Ask Size: -		 Check Point Software... 166.6987 USD 2078-12-31 Call
TeleTrader 08-27 Ukrainian troops allegedly trying to enter Russia near Belgorod
GlobeNewswire 08-14 Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 08-14 Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire 08-13 Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire 08-13 Replimune Announces First Patient Dosed in IGNYTE-3 Clinical Trial in Advanced Melanoma
GlobeNewswire 08-13 PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results
GlobeNewswire 08-13 Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire 08-12 Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024...
GlobeNewswire 08-12 Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in C...
GlobeNewswire 08-12 Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates
GlobeNewswire 08-08 ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 08-08 Bioatla Reports Second Quarter 2024 Financial Results and Highlights Recent Progress
GlobeNewswire 08-08 PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting
GlobeNewswire 08-08 Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08-07 PDS Biotech to Announce Second Quarter Financial Results on August 13, 2024
GlobeNewswire 08-06 ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors
GlobeNewswire 08-06 Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 08-06 BioXcel Therapeutics Reports Second Quarter 2024 Financial Results
GlobeNewswire 08-05 PDS Biotech Announces Abstract Accepted for Presentation at ESMO Congress 2024
GlobeNewswire 08-05 BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 08-05 Genmab Takes Full Control of Acasunlimab Development Program
TeleTrader 08-03 Israeli delegation returns from Egypt
GlobeNewswire 08-01 Shattuck Labs Reports Second Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 08-01 PDS Biotech Aligns with FDA on Phase 3 Trial in HPV16-Positive First-Line Recurrent or Metastatic He...
GlobeNewswire 08-01 Medicenna Reports First Quarter Fiscal 2025 Financial Results and Announces First Complete Responder...